Stability of AML1 (Core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5080-5087

  Amtoft, Henrik W ^a   Sørensen, Annette B ^a   Bareil, Corinne ^a,c   Schmidt, Jörg ^b   Luz, Arne ^b   Pedersen, Finn Skou ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Laboratoire de Biochimie Genetique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE REARRANGEMENT; LEUKEMOGENESIS; MOUSE; MURINE LEUKEMIA VIRUS; NEWBORN; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS CARCINOGENESIS; VIRUS MUTANT;

EID: 0030946084     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5080-5087.1997     Document Type: Article

References (42)

1. Bae, S. C., L. Y. Yamaguchi, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2aB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809-814.
2. Bae, S.-C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and Y. Ito. 1994. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14:3242-3252.
3. Ben-David, Y., and A. Bernstein. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831-834.
4. Boral, A. L., S. A. Okenquist, and J. Lenz. 1989. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63:76-84.
5. Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248-254.
6. Corcoran, L. M., J. M. Adams, A. R. Dunn, and S. Cory. 1984. Murine T-lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell 37:113-122.
7. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
8. Ethelberg, S., B. Hallberg, J. Lovmand, J. Schmidt, A. Luz, T. Grundström, and F. S. Pedersen. 1997. Second site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J. Virol. 71:1196-1206.
9. Fan, H. 1990. Influences of the long-terminal repeats on retrovirus pathogenicity. Semin. Virol. 1:165-174.
10. Hallberg, B., and T. Grundström. 1988. Tissue specific sequence motifs in the enhancer of the leukemogenic mouse retrovirus SL3-3. Nucleic Acids Res. 16:5927-5944.
11. Hallberg, B., J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundström. 1991. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65:4177-4181.
12. Holland, C. A., C. Y. Thomas, S. K. Chattopadhyay, C. Koehne, and P. V. O'Donnell. 1989. Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses. J. Virol. 63:1284-1292.
13. Hsiang, Y. H., D. Spencer, S. Wang, N. A. Speck, and D. H. Raulet. 1993. The role of viral "core" motif-related sequences in regulating T cell receptor γ and δ gene expression. J. Immunol. 150:3905-3916.
14. Kung, H. J., C. Boerkoel, T. H. Carter. 1991. Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. Curr. Top. Microbiol. Immunol. 171:1-25.
15. Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308:467-470.
16. Li, V., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
17. LoSardo, J. E., A. L. Boral, and J. Lenz. 1990. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity. J. Virol. 64:1756-1763.
18. Marcu, K. B., J. Banerji, N. A. Penucavage, R. Lang, and N. Arnheim. 1980. 5′ flanking region of immunoglobulin heavy chain constant region displays length heterogeneity in germlines of inbred mouse strains. Cell 22:187-196.
19. Morrison, H. L., B. Soni, and J. Lenz. 1995. Long terminal repeat core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455.
20. Nieves, A., L. S. Levy, and J. Lenz. 1997. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3. J. Virol. 71:1213-1219.
21. Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, M. Naito-Fujimoto, Y. Ito, and K. Shigesada. 1993. Molecular cloning and characterization of PEBP2P, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBPa. Virology 194:314-331.
22. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ho. 1993. PEBP2/PEM represents a new family of transcription factors homologous to the products of the Drosophila runt and the human AMLI. Proc. Natl. Acad. Sci. USA 90:6859-6863.
23. Okuda, T., J. van Deursen, S. Hiebert, G. Grosveld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
24. Pattengale P. K. 1994. Neoplastic lesions of the mouse lymphoid system, p. 168-176. In P. Bannasch and W. Goessner (ed.), Pathology of neoplasia and preneoplasia in rodents. Schattauer, Stuttgart, Germany.
25. Prosser, H. M., D. Wotten, A. Gegonne, A. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1992. A novel phorbol ester response element within the human T cell receptor β enhancer. Proc. Natl. Acad. Sci. USA 89:9934-9938.
26. Redondo, J. M., J. L. Pfohl, C. Hernandez-Munain, S. Wang, N. A. Speck, and M. S. Krangel. 1992. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor δ and murine leukemia virus enhancers. Mol. Cell. Biol. 12:4817-4823.
27. Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862-866.
28. Schmidt, J., V. Erfie, F. S. Pedersen, H. Rohmer, H. Schetters, K.-H. Marquardt, and A. Luz. 1984. Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J. Gen. Virol. 65:2237-2248.
29. Selten, G., H. T. Cuypers, and A. Berns. 1985. Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J. 4:1793-1798.
30. Sørensen, A. B., M. Duch, H. W. Amtoft, P. Jørgensen, and F. S. Pedersen. 1996. Sequence tags of proviral integration sites in DNA of tumors induced by the murine retrovirus SL3-3. J. Virol. 70:4063-4070.
31. Sørensen, A. B., M. Duch, P. Jørgensen, and F. S. Pedersen. 1993. Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J. Virol. 67:7118-7124.
32. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair direct repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101-1110.
33. Speck, N. A., B. Renjifo, E. Golemis, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
34. Speck, N. A., B. Renjifo, and N. Hopkins. 1990. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J. Virol. 64:543-550.
35. Steffen, D. 1984. Proviruses are adjacent to c-myc in some murine leukemia virus-induced lymphomas. Proc. Natl. Acad. Sci. USA 81:2097-2101.
36. Thomas, C. Y. 1986. AKR ecotropic murine leukemia virus SL3-3 forms envelope gene recombinants in vivo. J. Virol. 59:23-30.
37. Thomas, C. Y., J. D. Nuckols, C. Murphy, and D. Innes. 1993. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus. Virology 193:1013-1017.
38. Thornell, A., B. Hallberg, and T. Grundström. 1988. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8:1625-1637.
39. Thornell, A., B. Hallberg, and T. Grundström. 1991. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65:42-50.
40. Tsichlis P. N., P. G. Strauss, and L. F. Hu. 1983. A common region for proviral DNA integration in MoMuLV-induced rat thymic lymphomas. Nature (London) 302:445-449.
41. Tsichlis, P. N., and P. A. Lazo. 1991. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr. Top. Microbiol. Immunol. 171:95-171.
42. Wang, S., Q. Wang, B. E. Crute, I. N. Melnikova, S. R. Keller, and N. A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324-3339.